Showing results (131-140 of 175) with videos related to
Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|October 14, 2011
A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitorsMaria José Buzon, Itziar Erkizia, Christian Pou, et al.The Journal of Experimental Medicine|March 25, 2009
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipientsHayley Crawford, Wendy Lumm, Alasdair Leslie, et al.Nano Today|August 16, 2021
Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cellsAntonio Astorga-Gamaza, Michele Vitali, Mireya L Borrajo, et al.Journal of Mass Spectrometry : JMS|November 15, 2024
Phytochemical Profiling by HPLC-ESI-MS/MS and In Vitro Investigation of the Antidiabetic Activity of Cassia bakeriana Bark Extract and FractionsDiego G Prado, Allisson B Justino, Tiara da C Silva, et al.Journal of Virology|March 16, 2006
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1Javier Martinez-Picado, Julia G Prado, Elizabeth E Fry, et al.Nature Communications|November 24, 2025
Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latencyA Gallego-Cortés, N Sánchez-Gaona, C Mancebo-Pérez, et al.Frontiers in Immunology|May 27, 2022
Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-SeroconvertorsAthina Kilpeläinen, Esther Jimenez-Moyano, Oscar Blanch-Lombarte, et al.Journal of Virology|May 18, 2007
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infectionHayley Crawford, Julia G Prado, Alasdair Leslie, et al.BMJ Open|April 20, 2023
Symptoms and signs of lung cancer prior to diagnosis: case-control study using electronic health records from ambulatory care within a large US-based tertiary care centreMaria G Prado, Larry G Kessler, Margaret A Au, et al.Human Vaccines & Immunotherapeutics|April 30, 2025
Safety and immunogenicity of PHH-1V booster against SARS-CoV-2 variants, including omicron subvariants: Results from a phase IIb open-label extension studyMaría Jesús López, Maria Del Mar Vazquez, Melchor Alvarez-Mon, et al.Pageof 18